secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beam Therapeutics Inc. (BEAM)
CIK:        0001745999
Form:       8-K
Filed at:   2025-12-11T23:59:59+00:00
Accession:  0001193125-25-316043
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 2.01
LLM model:  deepseek-v4-flash:cloud@v2

Beam Therapeutics nets $255.1M cash from sale of Orbital stake in BMS acquisition
--------------------------------------------------------------------------------

- Beam received $255.1M in closing cash plus up to ~$26.3M from escrow for its 75M shares (17% fully diluted) of Orbital.
- Bristol-Myers Squibb completed acquisition of Orbital on December 8, 2025, triggering the payout.
- Beam to update cash runway guidance at the 2026 J.P. Morgan Healthcare Conference.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1745999/000119312525316043/0001193125-25-316043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1745999/000119312525316043/beam-20251208.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-316043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer